Published in Drug Law Weekly, September 20th, 2005
A convenient once-a-day tablet, Singulair has been proven to help relieve a broad range of indoor and outdoor allergy symptoms for up to 24 hours.
"Allergic rhinitis is one of the most common allergic conditions today, with approximately 50 million people in the United States suffering some form of the condition," said Gailen Marshall Jr., MD, PhD, director of the Division of Clinical Immunology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.